Metformin Ratiopharm

Metformin, the active ingredient in Metformin Ratiopharm, is a biguanide presented as a tablet for oral use. It is prescribed to improve blood glucose control in adults with type 2 diabetes mellitus and related insulin‑resistance conditions.

GNH USA supplies Metformin Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Ratiopharm is a biguanide indicated for disorders of glucose metabolism and related insulin‑resistance states. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Prediabetes (impaired glucose tolerance): reduces the risk of progression to overt diabetes. - Polycystic ovary syndrome (PCOS): improves insulin sensitivity and may help regulate menstrual cycles.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools, especially at treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycaemia: when combined with insulin or secretagogues. - Hepatic failure: worsening liver function may precipitate toxicity. - Stevens‑Johnson syndrome: severe skin reactions. - Anemia: hemolytic or aplastic processes. - Pancreatitis: inflammation of the pancreas.

Metformin requires careful monitoring and patient education to minimise risks. - Renal function assessment: avoid use in severe renal impairment (eGFR <30 mL/min/1.73 m²). - Hepatic function monitoring: contraindicated in acute liver disease. - Lactic acidosis risk: discontinue before surgeries or radiographic contrast procedures. - Elderly patients: start at lower doses and titrate slowly. - Alcohol consumption: limit intake to reduce lactic acidosis risk. - Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: may raise plasma metformin concentrations. - Rifampicin: reduces metformin exposure, potentially diminishing glucose‑lowering effect.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics (loop or thiazide): can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function when combined. - Alcohol: enhances risk of lactic acidosis, especially with excessive intake.